Suresh Kumar

4.2k total citations · 1 hit paper
41 papers, 2.9k citations indexed

About

Suresh Kumar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Suresh Kumar has authored 41 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Suresh Kumar's work include Ubiquitin and proteasome pathways (19 papers), Cancer-related Molecular Pathways (8 papers) and NF-κB Signaling Pathways (6 papers). Suresh Kumar is often cited by papers focused on Ubiquitin and proteasome pathways (19 papers), Cancer-related Molecular Pathways (8 papers) and NF-κB Signaling Pathways (6 papers). Suresh Kumar collaborates with scholars based in United States, India and Canada. Suresh Kumar's co-authors include Serge Y. Fuchs, Benjamin Nicholson, Vladimir S. Spiegelman, Harikrishna Nakshatri, Kathy D. Miller, Hiromitsu Kishimoto, Kent W. Christopherson, Poornima Bhat‐Nakshatri, Hal E. Broxmeyer and John J. Krolewski and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Suresh Kumar

40 papers receiving 2.8k citations

Hit Papers

NF-κ B Promotes Breast Cancer Cell Migration and Metastas... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh Kumar United States 20 1.9k 1.2k 672 481 310 41 2.9k
Eri Oda Japan 13 1.9k 1.0× 1.2k 1.0× 616 0.9× 387 0.8× 196 0.6× 34 2.9k
Ulrich Maurer Germany 26 2.4k 1.3× 813 0.7× 707 1.1× 407 0.8× 209 0.7× 43 3.4k
Shu‐ichi Matsuzawa United States 29 1.9k 1.0× 528 0.4× 664 1.0× 404 0.8× 335 1.1× 65 2.6k
Thomas Chittenden United States 11 1.8k 1.0× 1.5k 1.2× 525 0.8× 328 0.7× 143 0.5× 25 3.4k
Ramin Massoumi Sweden 25 2.0k 1.1× 859 0.7× 819 1.2× 1.0k 2.1× 267 0.9× 74 2.9k
Takehiko Dohi United States 22 2.7k 1.4× 793 0.6× 477 0.7× 464 1.0× 482 1.6× 39 3.3k
Katja Pokrovskaja Tamm Sweden 30 1.3k 0.7× 1.0k 0.8× 606 0.9× 268 0.6× 146 0.5× 62 2.4k
Haopeng Wang China 23 1.4k 0.7× 1.1k 0.9× 1.4k 2.1× 754 1.6× 214 0.7× 74 3.1k
James D. Bretz United States 15 2.6k 1.3× 617 0.5× 1.3k 1.9× 590 1.2× 248 0.8× 24 3.3k
Chunqing Guo United States 29 1.5k 0.8× 611 0.5× 1.2k 1.9× 520 1.1× 242 0.8× 66 2.9k

Countries citing papers authored by Suresh Kumar

Since Specialization
Citations

This map shows the geographic impact of Suresh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Kumar more than expected).

Fields of papers citing papers by Suresh Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Kumar. The network helps show where Suresh Kumar may publish in the future.

Co-authorship network of co-authors of Suresh Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Kumar. A scholar is included among the top collaborators of Suresh Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Kumar. Suresh Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sterner, David E., et al.. (2025). Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities. Scientific Reports. 15(1). 22961–22961.
2.
Huang, Chengqun, Jon Sin, David E. Sterner, et al.. (2024). Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364. European Heart Journal. 46(4). 380–393. 12 indexed citations
3.
Kumar, Suresh, Michael R. Mattern, Matthew S. Goldberg, & Tauseef R. Butt. (2023). The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease. NeuroMolecular Medicine. 25(3). 313–329. 8 indexed citations
4.
Sterner, David E., et al.. (2022). A Method to Monitor Activity of SARS-CoV-2 Nsp3 from Cells. Methods in molecular biology. 2591. 269–282. 2 indexed citations
5.
Takahashi, Nobuyuki, Sehyun Kim, Vinodh N. Rajapakse, et al.. (2021). Replication Stress Defines Distinct Molecular Subtypes Across Cancers. SSRN Electronic Journal. 6 indexed citations
6.
Arora, Ritu, Ruchi Goel, Ravi Meher, et al.. (2021). Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 – A Preliminary Report from a Single Hospital. Clinical ophthalmology. Volume 15. 3505–3514. 21 indexed citations
7.
O’Leary, Claire E., Lynn A. Spruce, Hua Ding, et al.. (2016). Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nature Communications. 7(1). 11226–11226. 24 indexed citations
8.
Ahmed, Shiek S. S. J., Rahat Husain, Suresh Kumar, & Ramakrishnan Veerabathiran. (2016). Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis. Journal of the Neurological Sciences. 368. 255–262. 26 indexed citations
9.
Kumar, Suresh, Jian Wu, Feng Wang, et al.. (2016). Abstract 559: Small molecule T-reg inhibitors for cancer immunotherapy. Cancer Research. 76(14_Supplement). 559–559. 1 indexed citations
10.
Laha, R., et al.. (2014). Epidemiology of Gastrointestinal Parasitism in Pigs in Subtropical Hill Zone of Meghalaya. 27(1). 2 indexed citations
11.
Altun, Mikael, Holger Kramer, Lianne I. Willems, et al.. (2011). Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes. Chemistry & Biology. 18(11). 1401–1412. 310 indexed citations
12.
Kumar, Suresh, et al.. (2010). Comparative efficacy of various miticidal drugs against canine scabies. INTAS POLIVET. 11(1). 60–64. 1 indexed citations
13.
Ács, Géza, György Paragh, Xiaowei Xu, & Suresh Kumar. (2008). Constitutively active erythropoietin receptor variants in human ovarian and breast cancers. Cancer Research. 68. 3428–3428. 1 indexed citations
14.
Lin, Douglas I., Olena Barbash, Suresh Kumar, et al.. (2006). Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex. Molecular Cell. 24(3). 355–366. 299 indexed citations
15.
Kumar, Suresh & Robert Smail Jack. (2006). Origin of monocytes and their differentiation to macrophages and dendritic cells. PubMed. 12(5). 278–284. 19 indexed citations
16.
Clevenger, Charles V., Suresh Kumar, Puthiyaveettil N. Raghunath, et al.. (2005). Stabilization of prolactin receptor in breast cancer cells. Oncogene. 25(13). 1896–1902. 42 indexed citations
17.
Fuchs, Serge Y., Vladimir S. Spiegelman, & Suresh Kumar. (2004). The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene. 23(11). 2028–2036. 270 indexed citations
18.
Kumar, Suresh, John J. Krolewski, & Serge Y. Fuchs. (2004). Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor. Journal of Biological Chemistry. 279(45). 46614–46620. 119 indexed citations
19.
Kumar, Suresh, Hiromitsu Kishimoto, Hui Lin Chua, et al.. (2003). Interleukin-1α Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer. American Journal Of Pathology. 163(6). 2531–2541. 64 indexed citations
20.
Kumar, Suresh. (2003). SCFHOS ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-  receptor. The EMBO Journal. 22(20). 5480–5490. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026